JSM2026
Back to all people

Lingyun Liu

Vertex Pharmaceuticals
1 appearance in the program

Sessions & presentations

Recent Advances and Evolving Challenges in Seamless Phase 2/3 Clinical Trial Designs
Presentation: Dose Switching After Interim Dose Selection in Seamless Two-Stage Adaptive Designs
Topic-Contributed Paper Session · Wed, Aug 5 , 2:00 PM
Speaker